Milestone PharmaceuticalsMIST
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 40 institutions reported holding Milestone Pharmaceuticals Inc. (MIST) in their 13F filings, down 3 from Q1 2024. 3 opened new positions and 6 sold out. The largest holders were BlackRock Inc. ($6.6M), RTW Investments, LP ($4.3M) and Millennium Management ($3.7M). 2 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Milestone Pharmaceuticals Inc.
- CUSIP
- 59935V107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $111K |
| Exits | 6 | $2.9M |
All 13F filers, Q1 2024 → Q2 2024: 936,486 shares bought and 2,099,706 shares sold, net −1,163,220 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 40 holders
| BlackRock Inc. | 0.00% | No change | 4,971,344 | $6.6M |
| RTW Investments, LP | 0.07% | No change | 3,256,102 | $4.3M |
| Millennium Management | 0.00% | Reduce -3.7% | 2,749,930 | $3.7M |
| Alta Fundamental Advisers LLC | 1.54% | Add +12.1% | 2,658,589 | $3.5M |
| Lion Point Capital, LP | 9.68% | Add +1.7% | 2,340,207 | $3.1M |
| Citadel Advisors | 0.00% | Reduce -5.5% | 2,147,344 | $2.9M |
| Orbimed Advisors LLC | 0.05% | No change | 2,000,000 | $2.6M |
| Nantahala Capital Management, LLC | 0.23% | No change | 1,750,000 | $2.3M |
| Goldman Sachs Group Inc. | 0.00% | No change | 1,353,067 | $1.8M |
| Bleichroeder LP | 0.52% | No change | 1,326,085 | $1.8M |
| Stonepine Capital Management, LLC | 1.49% | Reduce -15.3% | 1,239,199 | $1.6M |
| BML Capital Management, LLC | 1.07% | Add +82.0% | 1,102,895 | $1.5M |
| Altium Capital Management LLC | 0.55% | Reduce -16.5% | 1,012,368 | $1.3M |
| Morgan Stanley | 0.00% | Add +1.1% | 828,654 | $1.1M |
| Ikarian Capital, LLC | 0.19% | No change | 466,019 | $620K |
| Boxer Capital, LLC | 0.02% | No change | 309,007 | $408K |
| ADAR1 Capital Management, LLC | 0.05% | No change | 202,460 | $267K |
| Ancora Advisors LLC | 0.00% | No change | 60,000 | $79K |
| Envestnet Asset Management Inc. | 0.00% | Add +14.8% | 59,523 | $79K |
| Squarepoint Ops LLC | 0.00% | New | 54,684 | $73K |
| Dimensional Fund Advisors LP | 0.00% | No change | 39,450 | $52K |
| Boothbay Fund Management, LLC | 0.00% | No change | 30,779 | $41K |
| Atria Investments, Inc | 0.00% | New | 27,991 | $37K |
| Northern Trust Corp. | 0.00% | Reduce -1.9% | 27,784 | $37K |
| BNP Paribas Financial Markets | 0.00% | Add +45.6% | 24,600 | $33K |
| Cetera Investment Advisers | 0.00% | Add +18.7% | 20,689 | $27K |
| Clear Creek Financial Management, LLC | 0.00% | Reduce -22.0% | 19,500 | $26K |
| State Street Corp. | 0.00% | No change | 18,923 | $25K |
| Geode Capital Management, LLC | 0.00% | No change | 17,576 | $23K |
| Beta Wealth Group, Inc. | 0.01% | No change | 14,127 | $19K |
| Creative Planning | 0.00% | No change | 13,080 | $17K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 10,500 | $14K |
| Valeo Financial Advisors, LLC | 0.00% | No change | 10,000 | $13K |
| National Bank of Canada | 0.00% | No change | 7,100 | $9K |
| Osaic Holdings, Inc. | 0.00% | Add +8.3% | 6,500 | $9K |
| Jones Financial Companies LLLP | 0.00% | New | 1,070 | $1K |
| Simplex Trading, LLC | 0.00% | Add +149.2% | 1,191 | $1K |
| Qube Research & Technologies Ltd | 0.00% | No change | 194 | $258 |
| Barclays PLC | 0.00% | No change | 100 | $132 |
| Oliver Lagore Vanvalin Investment Group | 0.00% | No change | 100 | $132 |
"% of holder's portfolio" is MIST's weight in each manager's 13F, not the share of Milestone Pharmaceuticals Inc. the manager owns.